ALTEOGEN Inc. (KOSDAQ:196170)

South Korea · Delayed Price · Currency is KRW

361,000

-15,500 (-4.12%)

At close: Feb 6, 2026

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Technical Services - Hyaluronic Medicine Technology (License-Out) Contracts, Milestone Revenue, Clinical Sample Supply, Technical Service Supply, etc	75.67B
Technical Services - Hyaluronic Medicine Technology (License-Out) Contracts, Milestone Revenue, Clinical Sample Supply, Technical Service Supply, etc Growth	-9.20%
Genetic Development and Development of Transgenic Plants and Animals Product	14.70B
Genetic Development and Development of Transgenic Plants and Animals Product Growth	8334.89%
Genetic Development and Development of Transgenic Plants and Animals Merchandise	10.03B
Genetic Development and Development of Transgenic Plants and Animals Merchandise Growth	-22.53%
Other Technical Services	2.39B
Technical Services - Ilia Biosimilar	68.06M

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Overseas	92.82B
Overseas Growth	11.32%
South Korea	10.03B
South Korea Growth	-23.65%